BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6192144)

  • 1. Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.
    Kasper DL; Baker CJ; Galdes B; Katzenellenbogen E; Jennings HJ
    J Clin Invest; 1983 Jul; 72(1):260-9. PubMed ID: 6192144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.
    Schifferle RE; Jennings HJ; Wessels MR; Katzenellenbogen E; Roy R; Kasper DL
    J Immunol; 1985 Dec; 135(6):4164-70. PubMed ID: 3934276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and serology of the native polysaccharide antigen of type Ia group B streptococcus.
    Jennings HJ; Rosell KG; Kasper DL
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2931-5. PubMed ID: 6156459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.
    Wessels MR; Benedí WJ; Jennings HJ; Michon F; DiFabio JL; Kasper DL
    Infect Immun; 1989 Apr; 57(4):1089-94. PubMed ID: 2494110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Rodewald AK; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1993 Nov; 61(11):4760-6. PubMed ID: 8406875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
    J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of type-specific polysaccharide antigen from group B type Ib streptococci.
    Tai JY; Gotschlich EC; Lancefield RC
    J Exp Med; 1979 Jan; 149(1):58-66. PubMed ID: 33225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide.
    Wessels MR; DiFabio JL; Benedì VJ; Kasper DL; Michon F; Brisson JR; Jelínková J; Jennings HJ
    J Biol Chem; 1991 Apr; 266(11):6714-9. PubMed ID: 2016287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide.
    Kane JA; Karakawa WW
    J Immunol; 1977 Jun; 118(6):2155-60. PubMed ID: 68081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.
    Brigtsen AK; Kasper DL; Baker CJ; Jennings HJ; Guttormsen HK
    J Infect Dis; 2002 May; 185(9):1277-84. PubMed ID: 12001045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.
    Jennings HJ; Lugowski C; Kasper DL
    Biochemistry; 1981 Aug; 20(16):4511-8. PubMed ID: 6170311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
    Madoff LC; Paoletti LC; Tai JY; Kasper DL
    J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.
    Kotloff KL; Fattom A; Basham L; Hawwari A; Harkonen S; Edelman R
    Vaccine; 1996 Apr; 14(5):446-50. PubMed ID: 8735558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci.
    Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G
    Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Existence of multiple immunodeterminants in the type-specific capsular substance of group B type Ia streptococci.
    Kane JA; Karakawa WW
    Infect Immun; 1978 Mar; 19(3):983-91. PubMed ID: 76609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple and sensitive enzyme immunoassay for determination of soluble type-specific polysaccharide from group B streptococci.
    Holm SE; Håkansson S
    J Immunol Methods; 1988 Jan; 106(1):89-94. PubMed ID: 3276789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.
    Wessels MR; Pozsgay V; Kasper DL; Jennings HJ
    J Biol Chem; 1987 Jun; 262(17):8262-7. PubMed ID: 3298228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-specific polysaccharide antigens of group B streptococci. II. The chemical basis for serological specificity of the type II HCl antigen.
    Freimer EH
    J Exp Med; 1967 Mar; 125(3):381-92. PubMed ID: 6018238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis.
    Jennings HJ; Roy R; Michon F
    J Immunol; 1985 Apr; 134(4):2651-7. PubMed ID: 2579148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.